Cargando…
Institutional experience using interstitial brachytherapy for the treatment of primary and recurrent pelvic malignancies
PURPOSE: The study assessed the outcomes of patients at a single institution with locally advanced primary and recurrent pelvic malignancies treated with interstitial high-dose-rate (HDR) or low-dose-rate (LDR) brachytherapy (BT), using a modified Syed-Neblett template. MATERIAL AND METHODS: Between...
Autores principales: | Aridgides, Paul, Onderdonk, Benjamin, Cunningham, Mary, Daugherty, Emily, Du, Lingyun, Bunn, W. Douglas, Agarwal, Rinki, Hahn, Seung Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965502/ https://www.ncbi.nlm.nih.gov/pubmed/27504125 http://dx.doi.org/10.5114/jcb.2016.61062 |
Ejemplares similares
-
Advantages of real-time transabdominal ultrasound guidance in combined interstitial/intracavitary cervical brachytherapy: a case-based review
por: Thibodeau, Ryan, et al.
Publicado: (2021) -
Cesium-131 Interstitial Brachytherapy for Recurrent Malignancies of Skull Base
por: Savard, Corey, et al.
Publicado: (2019) -
CT-guided (125)I interstitial brachytherapy for pelvic recurrent cervical carcinoma after radiotherapy
por: Tong, Lina, et al.
Publicado: (2017) -
A Case of Primary Signet-Ring Cell Cervical Carcinoma Treated with Chemoradiation, Brachytherapy, and Adjuvant Hysterectomy
por: Salmen, Nicole, et al.
Publicado: (2021) -
Technical Note: High-Dose-Rate Interstitial Brachytherapy for Pelvic Sidewall Recurrence Using Intraperitoneal Spacers
por: Miyata, Yusaku, et al.
Publicado: (2022)